Healio Rheumatology


The following articles appeared in the print edition of HEALIO RHEUMATOLOGY.

Table of Contents
Cover Story

A Clearer Clinical Picture: Exploring Shifts in Use, Cost of Diagnostic Imaging


Direct-to-consumer Ads and the Rheumatologist: Time for Value-based Care Approach

Leonard H. Calabrese, DO


Battle for Enbrel: Ruling on Patent Lawsuit Could Transform US Biosimilar Marketplace

Imagine Dragons Frontman Raises Awareness for Ankylosing Spondylitis With ‘Monster Pain in the AS’

In the Journals

Black, Latina Women With Knee OA Desire Timelier Information on Therapy Options

Footwear Intervention Fails to Improve Gout Foot Pain

Sugar-sweetened Beverages Linked to 208% Increase in Incident Gout

Rheumatologists, Patients Share Common Barriers to Controlling RA

Racial, Ethnic Minorities at Greater Risk for Severe Lupus Manifestations

Meeting News

No Link Between TNF Inhibitors, Increased Risk for Cancer in PsA

More than Half of Patients With Arthritis Report CBD Use

Tapering Glucocorticoids Effective in Two-thirds of Tocilizumab-treated Patients With RA

Rosacea, Other ‘Mimic’ Skin Conditions Often Misdiagnosed as Rheumatic Diseases

Ixekizumab Bests Adalimumab in PsA in Head-to-head Comparison

IgG4 Role Overplayed in the Inflammatory ‘Symphony’ of IgG4-related Disease

Partial Knee Replacement Increases Risk for Long-term Revision

Origin Stories

All the President's Secrets: John F. Kennedy and Addison's Disease

Q&A With Healio Rheumatology

Speaking the Language: Health Care Execs Join United Rheumatology to Advocate for Independent Practice

Trend Watch

Rheumatologists Vary on When to Discontinue Arthritis Drugs During Unplanned Pregnancies

ACR: Proposed Legislation Could Eliminate Prior Authorization ‘Hurdles’ in Medicare Advantage

Abatacept has Highest Overall Retention Rate Among Seven Biologics for RA

No Impact on Safety, Efficacy in Etanercept-to-biosimilar Switch in RA